Review
doi: 10.1016/j.bjae.2018.01.005.
Epub 2018 Mar 16.
Steroid use in critical care
Affiliations
- PMID: 33456822
- PMCID: PMC7807942
- DOI: 10.1016/j.bjae.2018.01.005
Item in Clipboard
Review
Steroid use in critical care
BJA Educ.
2018 May.
No abstract available
Conflict of interest statement
None declared.
Similar articles
-
The Unique Relationship between Neuro-Critical Care and Critical Illness-Related Corticosteroid Insufficiency : Implications for Neurosurgeons in Neuro-Critical Care.J Korean Neurosurg Soc. 2023 Jun 12. doi: 10.3340/jkns.2026.0061. Online ahead of print. J Korean Neurosurg Soc. 2023. PMID: 37308453
-
Prescription of Steroids in General Pediatric Intensive Care Patients-A Two-Center Retrospective Observational Study.Pediatr Crit Care Med. 2023 Jan 1;24(1):e54-e59. doi: 10.1097/PCC.0000000000003093. Epub 2022 Oct 14. Pediatr Crit Care Med. 2023. PMID: 36239492
-
Steroid cover for dental patients on long-term steroid medication: proposed clinical guidelines based upon a critical review of the literature.Br Dent J. 2004 Dec 11;197(11):681-5. doi: 10.1038/sj.bdj.4811857. Br Dent J. 2004. PMID: 15592544 Review.
-
Steroid Use in the NICU: Treatment and Tapering.Neoreviews. 2023 Apr 1;24(4):e207-e216. doi: 10.1542/neo.24-4-e207. Neoreviews. 2023. PMID: 37002396 Review.
-
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Aug 17;21(1):724. doi: 10.1186/s13063-020-04645-z. Trials. 2020. PMID: 32807241 Free PMC article.
Cited by
-
Monitoring of the Forgotten Immune System during Critical Illness-A Narrative Review.Medicina (Kaunas). 2022 Dec 28;59(1):61. doi: 10.3390/medicina59010061. Medicina (Kaunas). 2022. PMID: 36676685 Free PMC article. Review.
-
Improving steroid and immunosuppressant prescribing and treatment plans: quality improvement project on an intensive care unit.Future Healthc J. 2022 Jul;9(Suppl 2):111-112. doi: 10.7861/fhj.9-2-s111. Future Healthc J. 2022. PMID: 36311003 Free PMC article. No abstract available.
-
Real-world evidence of the use of glucocorticoids for severe COVID-19.Ther Adv Endocrinol Metab. 2022 Jan 19;13:20420188211072704. doi: 10.1177/20420188211072704. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 35070258 Free PMC article.
-
Phytochemistry and Evaluation of the Anti-Inflammatory Activity of the Hydroethanolic Extract of Virola elongata (Benth.) Warb. Stem Bark.Biology (Basel). 2024 Sep 28;13(10):776. doi: 10.3390/biology13100776. Biology (Basel). 2024. PMID: 39452085 Free PMC article.
-
Critical illness-related corticosteroid insufficiency: latest pathophysiology and management guidelines.Acute Crit Care. 2024 Aug;39(3):331-340. doi: 10.4266/acc.2024.00647. Epub 2024 Aug 30. Acute Crit Care. 2024. PMID: 39266268 Free PMC article.
References
-
- British National Formulary. Glucocticoid therapy. Available from: https://bnf.nice.org.uk/treatment-summary/glucocorticoid-therapy.html (Accessed 25 July 2017).
-
- Annane D., Sébille V., Charpentier C. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862–871. - PubMed
-
- Sprung C.L., Annane D., Keh D. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111–124. - PubMed
-
- Keh D., Trips E., Marx G. Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA. 2016;316:1775–1785. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
